Journal of Equine Veterinary Science
Volume 29, Issue 6 , Pages 547-550, June 2009

Clinical Experience Using MicroLactin for the Treatment of Equine Inflammatory Disease

  • Thomas R. Bello, DVM, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Thomas R. Bello, DVM, PhD, Sandhill Equine Center, PO Box 1313, Southern Pines, NC 28388.
    • ,
  • Tammy M. Allen, RVT

Sandhill Equine Center, Southern Pines, NC

Abstract 

MicroLactin is a patented milk protein concentrate whose mode of action is proposed to inhibit neutrophil activation in inflammation and to bolster the immune response in musculoskeletal diseases. MicroLactin was empirically used in the treatment of a series of equine clinical cases. MicroLactin was given in two trials to 166 horses in which neutrophils were associated with an inflammatory response. The primary clinical groups having the greatest positive responders to the use of MicroLactin were: respiratory (92%), joint lameness/foot trauma (90%), muscle injury/myositis (92%), equine protozoal myeloencephalitis (EPM) (81%), skin trauma/hypersensitivity (89%), and toxic enteritis (89%). Positive clinical results were seen within 10 to 14 days when MicroLactin was used as a daily treatment either alone or in combination with other anti-inflammatory agents or as an adjunct to the primary treatment.

Keywords: Horse, Neutrophils, Inflammation, MicroLactin, Treatment

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 15.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This short communication dealing with a feed additive as a treatment for equine inflammatory disease is evidence and experience based. Neither editor endorses this product, but we have included this article as an encouragement for further evidence-based research on a treatment to improve equine health.

PII: S0737-0806(09)00489-4

doi:10.1016/j.jevs.2009.05.004

Journal of Equine Veterinary Science
Volume 29, Issue 6 , Pages 547-550, June 2009

Article Tools